Biote Stock (NASDAQ: BTMD) stock price, news, charts, stock research, profile.
Open | $5.99 |
Close | $6.11 |
Volume / Avg. | 208.41K / 257.82K |
Day Range | $5.92 - $6.22 |
52 Wk Range | 3.65 - 8.44 |
Market Cap | $189.37M |
P/E Ratio | 11.76 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 5.53% |
Days to Cover | 6.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biote (NASDAQ:BTMD) through any online brokerage.
Other companies in Biote’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Esperion Therapeutics (NASDAQ:ESPR), Telomir Pharmaceuticals (NASDAQ:TELO) and Trevi Therapeutics (NASDAQ:TRVI).
Biote has a consensus price target of $8.65.
The stock price for Biote (NASDAQ: BTMD) is $6.11 last updated September 19, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Biote.
Biote’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Biote.
Biote is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.